Causeway Capital Management Lowered Its Sanofi (SNY) Position; First Trust Enhanced Equity Income Fund Has 1.05 Sentiment

October 21, 2017 - By Marguerite Chambers

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. The company has market cap of $307.39 million. The Fund’s investment objective is to provide a high level of current income and gains and, to a lesser extent, capital appreciation. It currently has negative earnings. The Fund invests in a diversified portfolio of equity securities.

Causeway Capital Management Llc decreased Sanofi (SNY) stake by 68.25% reported in 2017Q2 SEC filing. Causeway Capital Management Llc sold 208,584 shares as Sanofi (SNY)’s stock rose 14.25%. The Causeway Capital Management Llc holds 97,036 shares with $4.65M value, down from 305,620 last quarter. Sanofi now has $125.41 billion valuation. The stock decreased 1.02% or $0.51 on October 20, reaching $49.51. About 917,432 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since October 21, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.

Analysts await Sanofi SA (ADR) (NYSE:SNY) to report earnings on October, 27. They expect $0.97 EPS, down 3.00% or $0.03 from last year’s $1 per share. SNY’s profit will be $2.46 billion for 12.76 P/E if the $0.97 EPS becomes a reality. After $0.74 actual EPS reported by Sanofi SA (ADR) for the previous quarter, Wall Street now forecasts 31.08% EPS growth.

Causeway Capital Management Llc increased Csra Inc stake by 533,419 shares to 6.22M valued at $197.47 million in 2017Q2. It also upped Baidu Inc (NASDAQ:BIDU) stake by 154,836 shares and now owns 3.76M shares. Verifone Sys Inc (NYSE:PAY) was raised too.

Among 11 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 0 Sell and 8 Hold. Therefore 27% are positive. Sanofi-aventis Sa had 19 analyst reports since October 15, 2015 according to SRatingsIntel. The rating was initiated by Argus Research with “Buy” on Thursday, April 6. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Reduce” rating given on Friday, April 7 by HSBC. The rating was upgraded by JP Morgan on Wednesday, April 12 to “Neutral”. Cowen & Co maintained it with “Hold” rating and $52.0 target in Tuesday, September 5 report. The stock of Sanofi SA (ADR) (NYSE:SNY) earned “Neutral” rating by Goldman Sachs on Monday, November 7. The firm earned “Hold” rating on Friday, October 13 by Cowen & Co. HSBC downgraded the shares of SNY in report on Tuesday, May 3 to “Hold” rating. BNP Paribas downgraded the stock to “Underperform” rating in Thursday, December 10 report. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Sell” rating given on Friday, March 31 by JP Morgan. The stock of Sanofi SA (ADR) (NYSE:SNY) earned “Neutral” rating by Piper Jaffray on Friday, September 23.

The stock increased 0.72% or $0.11 on October 20, reaching $15.39. About 75,869 shares traded or 42.29% up from the average. First Trust Enhanced Equity Income Fund (FFA) has risen 19.38% since October 21, 2016 and is uptrending. It has outperformed by 2.68% the S&P500.

Arete Wealth Advisors Llc holds 1.02% of its portfolio in First Trust Enhanced Equity Income Fund for 152,447 shares. Bulldog Investors Llc owns 115,620 shares or 0.84% of their US portfolio. Moreover, North Star Investment Management Corp. has 0.62% invested in the company for 315,172 shares. The New York-based Karpus Management Inc. has invested 0.54% in the stock. Blue Bell Private Wealth Management Llc, a Pennsylvania-based fund reported 65,064 shares.